Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells
The study was published online February 5 in the February 2008 edition (Volume 6, Issue 2) of the journal PLoS Biology. The research team found that the hypertension drugs diltiazem and verapamil increased the overall function of mutant lysosomal enzymes associated with the conditions Gaucher d...New DNA Tests Advances Treatment of Lysosomal Storage Diseases
A new set of laboratory tests using gene sequencing is able to help confirm 24 lysosomal storage diseases, providing physicians and patients the tools for much more accurate and rapid diagnosis. Lysosomal storage diseases are a group of more than 40 inherited and potentially life-threatening disor...Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome
...-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syn...ient activity of N-acetylgalactosamine 6-sulfatase (GALNS)causing excessive lysosomal storage of keratan sulfate (KS). This excessive storage causes a systemic s...Tips from the American Journal of Pathology
...n cells. Treatment with gangliosides reversed the lysosomal disruption, which suggests that gangliosides protect against the lysosomal damage of a-synuclein accumulation. Based on th... M: Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies...Cathepsin B increases apoptosis in fulminant hepatic failure
...ticle further indicated that LPS/D-Gal N-mediated cathepsin B expression initiates hepatocyte apoptosis in fulminant hepatic failure. Cathepsin B, a lysosomal cysteine protease, is a candidate for an apoptotic mediator originating from acidic vesicles. CA-074me is a selective inhibitor of cathepsin B , and i...BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
...BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today the initiation of the Morquio Clinical Assessment Program (MorCAP) for patients with the lysosomal storage disease Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. MorCAP is designed to augment available data on the disease by measur...St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease
...environment in a highly regulated process known as lysosomal exocytosis. These bags of enzymes, called lysosome... NEU1 regulates the pool of lysosomes destined for lysosomal exocytosis is by cutting off a sugar called sialic...omes to dock at the cell membrane and to engage in lysosomal exocytosis into the bone marrow environment. "Th...VIDEO from Medialink and Shire plc: Rare Diseases Must Be Top of the Health Agenda
...men with Fabry disease, compared with the general population. Fabry disease is one of a group of 45 similar genetic disorders, known collectively as lysosomal storage disorders. European Rare Disease Day is designed to improve the understanding, care and treatment of these kinds of diseases to improve the ...Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
...t has been the most rapid for any of Genzyme's lysosomal storage disorder treatments. In December, Gen...the first quarter of 2009. Newborn Screening for lysosomal storage disorders -- Based on its belief that ea...an lead to improved outcomes for patients with lysosomal storage disorders, and as part of its commitme...Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
... About Fabry Disease Fabry disease is a lysosomal storage disorder caused by inherited genetic mutat...e A (a-Gal A). Deficient a-Gal A activity leads to lysosomal accumulation of globotriaosylceramide (GL-3), whic...three lead pharmacological chaperone compounds for lysosomal storage disorders, Amigal, Plicera and AT2220. Und...BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
...-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syn...ent activity of N-acetylgalactosamine 6-sulfatase (GALNS) causing excessive lysosomal storage of keratan sulfate (KS). This excessive storage causes a systemic s...Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
...nd commercialize Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders. Under the collaboration, Shire received commercial right...ding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet me...Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
...nd commercialize Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders. Under the agreement, Shire received commercial rights ou...ding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet me...Amicus Therapeutics Announces Second Quarter 2008 Financial Results
...t a broader range of human genetic diseases beyond lysosomal storage diseases. As part of this effort, Amicus c...three lead pharmacological chaperone compounds for lysosomal storage disorders, Amigal, Plicera and AT2220. In ... increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genet...Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
...ation ("FDA") for the treatment of nephropathic cystinosis, a rare, genetic lysosomal storage disease. Raptor is currently developing DR Cysteamine, a proprietar...European Medicines Agency to treat nephropathic cystinosis, a rare, genetic lysosomal storage disease. DR Cysteamine is designed as an improved, enterically coat...Proteomics study yields clues as to how tuberculosis might be thwarting the immune system
...ith digestive enzymes from another cell organelle, called a lysosome, which fuses with the phagosome. Macrophages, like other kinds of cells, also use lysosomal enzymes for internal housekeeping. However, until now there has been no direct biochemical evidence of a link between phagocytosis and autophagy. W...In scientific first, Einstein researchers correct decline in organ function associated with old age
...ng in a buildup of undigested proteins within the cells. She also detected the primary cause for this age-related decline: a fall-off in the number of lysosomal receptors capable of binding chaperones and their damaged proteins. Could replenishing lost receptors in older animals maintain the efficiency of this...Gene therapy slows progression of fatal neurodegenerative disease in children
... (LINCL) is an autosomal recessive genetic disorder that causes degeneration of the central nervous system. It is a form of Batten disease, a group of lysosomal storage disease in which a lipofuscin-like material is not broken down and accumulates in neurons, causing cognitive impairment, visual failure, seizu...Penn researchers link cell's protein recycling systems
...egeneration. They use the fly eye, a neuron-rich tissue, as a surrogate for the brain because it is easy to visualize. They discovered that making the lysosomal system more or less active dramatically influenced the severity of neurodegeneration. “We found that whenever we knocked the lysosome system dow...Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease
...netic diseases that afflicts 1 in 5000 patients, typically children (called lysosomal storage diseases, described in more detail below), but which is often used ... one person in 5,000 is affected by a disease that falls into a category of lysosomal storage diseases. Currently there is no treatment for Sandhoff or ...Dangerous tricksters: Some bacterie use immune cells to reproduce
...lopment inside the macrophage, preventing acidification and merging with the lysosomes. As a result the bacteria are not exposed to the large array of lysosomal digestive enzymes and acid. Killing the killer 'Basically what this means is that the rhodococci manipulate their host cell, they make it them...Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
...in all. The oldest Duke patient transplanted for a lysosomal storage disease is now seven years old and has dev...niversal screening of all newborns for the genetic lysosomal storage diseases. The major barrier to universal n...esting itself would be relatively low. Although lysosomal storage diseases are rare ?fewer than 5,000 births...Genetic therapy reverses nervous system damage in animal model of inherited human disease
...t one day treat an entire class of diseases called lysosomal storage disorders which cause severe, sometimes fa...the disease itself is rare, AMD is one of about 50 lysosomal storage diseases, a class of diseases that account...hs disease, Hunter disease and Pompe disease. In a lysosomal storage disease, cellular debris accumulates withi...Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
...in all. The oldest Duke patient transplanted for a lysosomal storage disease is now seven years old and has dev...niversal screening of all newborns for the genetic lysosomal storage diseases. The major barrier to universal n...esting itself would be relatively low. Although lysosomal storage diseases are rare ?fewer than 5,000 births...Current human embryonic stem cell lines contaminated UCSD/Salk team finds
...ey determined that Neu5Gc gets into human cells by being engulfed in fluid droplets and then moved to the cytoplasm of the cell by a "pump" called the lysosomal sialic acid transporter. Varki noted that this pathway is an unusual and previously unknown one that may also be relevant to the entry of other small ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
...three lead pharmacological chaperone compounds for lysosomal storage disorders: Amigal, Plicera and AT2220. Und... increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genet...three lead pharmacological chaperone compounds for lysosomal storage disorders. Under the agreement, Shire rece...Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
...ly bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. FOLD -G ...Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
...ly bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. FOLD -G ...Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
...y bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. FOLD -G ...Publication of Shire plc's Annual Report 2008
... treatment of Metachromatic Leukodystrophy ('MLD') Shire has an ongoing enzyme replacement therapy program for the treatment of MLD, which is a lysosomal storage disorder that results from a deficiency in the enzyme arylsulfatase-A ('ASA'). In June 2008 Shire completed its acquisition from Zymenex of th...BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA
...-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syn...ent activity of N-acetylgalactosamine 6-sulfatase (GALNS) causing excessive lysosomal storage of keratan sulfate (KS). This excessive storage causes a systemic s...Human Cathepsin D from Calbiochem
Description:... Lyophilized. Lyophilized from 2 mM sodium phosphate buffer, pH 6.5. Cathepsin D from human liver. Cathepsin D is a major lysosomal aspartyl protease in mammalian cells produced as a 52 kDa proenzyme. Overexpression of cathepsin D in human breast cancers is associated with higher r...